Teen boys ’ HPV-vaccination rate hits almost 50 percent, CDC says
The rate of HPV vaccination among teen boys in the United States surged in 2015, suggesting that more parents and physicians are embracing the message that it's as important for boys to be vaccinated against the human papillomavirus as it is for girls. The Centers for Disease Control and Prevention reported Thursday that 49.8 percent […]Related:EpiPens are my armor against disaster. They shouldn’t be priced like a luxury.How violence could be hurting kids with HIVGene test can reduce chemo use among breast-cancer patients, study says (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - August 25, 2016 Category: Consumer Health News Source Type: news
1st HPV Test for Use With Preservative Fluid
Human papillomavirus responsible for 70 percent of cervical cancers (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - July 8, 2016 Category: Cancer & Oncology Authors: webmaster at doctorslounge.com Tags: Oncology, Pharmacy, FDA Approvals, Source Type: news
1st HPV Test for Use with Preservative Fluid
Human papillomavirus responsible for 70 percent of cervical cancers
Source: HealthDay
Related MedlinePlus Pages: Cervical Cancer Screening, HPV, Laboratory Tests (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - July 8, 2016 Category: Consumer Health News Source Type: news
1st HPV Test for Use With Preservative Fluid
Human papillomavirus responsible for 70 percent of cervical cancers (Source: Cancercompass News: Gynecological Cancer)
Source: Cancercompass News: Gynecological Cancer - July 8, 2016 Category: Cancer & Oncology Source Type: news
When It Comes To Cervical Cancer, Two Tests Are Better -- And Cheaper -- Than One
It is right that we constantly should be testing our assumptions about what keeps us healthy and what puts us at risk. New ideas and evidence that challenge current behaviors must be taken into consideration. But "new" isn't necessarily better, and many of our current practices - despite alternatives that by their very newness might seem better - remain the best option for care.
This is especially relevant now as OB-GYNs from around the country recently convened at the American Congress of Obstetricians and Gynecologists (ACOG) annual meeting to debate the latest topics related to cervical cancer screening. Powerful new ...
Source: Healthy Living - The Huffington Post - June 21, 2016 Category: Consumer Health News Source Type: news
VIDEO: Should the HPV test be a stand-alone cancer screening test?
WASHINGTON – Despite being approved by the Food and Drug Administration as a primary cervical cancer screening test starting at age 25, most medical societies recommend that the human papillomavirus... (Source: Family Practice News)
Source: Family Practice News - May 16, 2016 Category: Primary Care Source Type: news
Combining pap, hrHPV tests could drastically reduce cancer miss rates
Cytopathology researchers recently found that combining two diagnostic tests, Pap and high-risk human papillomavirus (hrHPV), dramatically decreased the chance of missing tumors and high-grade lesions by sevenfold. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - May 3, 2016 Category: Science Source Type: news
Get Tested for Sexually-Transmitted Infections
When Charlie Sheen disclosed his HIV infection last fall, sexually transmitted infections were back in the public eye. His case will likely contribute to the belief many people have that HIV is caused by sexual promiscuity or injection drug use, when in reality having unprotected sex with someone HIV-positive just one time can lead to HIV infection. April is STD Awareness Month. The new term for STD is STI -- sexually transmitted infection -- to focus on the infection rather than the disease it could lead to. One way to mark the occasion is to get tested for HIV and thus help eradicate the stigma. A focus on HIV for STD ...
Source: Healthy Living - The Huffington Post - April 5, 2016 Category: Consumer Health News Source Type: news
ACS Releases Long-term Care Guideline for Survivors of Head and Neck Cancer
By Stacy Simon The American Cancer Society has released a new Head and Neck Survivorship Care Guideline to help survivors of head and neck cancer and their primary care providers better manage their long-term care. The guideline addresses cancers of the oral cavity, tongue, lip, pharynx (throat), and larynx (voice box). Recommendations in the guideline may also apply to cancers of the salivary glands, nasal and paranasal sinuses, and nasopharynx. But it does not address cancers of the brain, thyroid, or esophagus because they are very different in terms of symptoms and treatment. RESOURCES: Head and Neck Cancer Surv...
Source: American Cancer Society :: News and Features - March 23, 2016 Category: Cancer & Oncology Tags: Oral Cavity and Oropharyngeal Cancer Laryngeal and Hypopharyngeal Cancer Salivary Gland Cancer Nasal Cavity and Paranasal Sinus Cancer Nasopharyngeal Cancer Source Type: news
Cuba Has Made At Least 3 Major Medical Innovations That We Need
By most measures, the United States' business-friendly environment has proven to be fertile for medical innovation. Compared to other countries, America has filed the most patents in the life sciences, is conducting most of the world's clinical trials and has published the most biomedical research. That's what makes the medical prominence of Cuba all the more surprising to those who view a free market as an essential driver of scientific discovery. Cuba is very poor, and yet the country has some of the healthiest, most long-lived residents in the world -- as well as a medical invention or two that could run circl...
Source: Science - The Huffington Post - March 15, 2016 Category: Science Source Type: news
Electronic health records can help catch undiagnosed cases of Type 2 diabetes, UCLA researchers find
In 2012, a group of UCLA researchers set out to mine thousands of electronic health records for a more accurate and less expensive way to identify people who have undiagnosed Type 2 diabetes. The researchers got much more than they bargained for.
Not only did they develop an algorithm with the potential to vastly increase the number of correct diagnoses of the disease by refining the pool of candidates who are put forward for screening; they also uncovered several previously unknown risk factors for diabetes, including a history of sexual and gender identity disorders, intestinal infections and a category of illnesses tha...
Source: UCLA Newsroom: Health Sciences - February 16, 2016 Category: Universities & Medical Training Source Type: news
Cancer Centers Urge More People to Get the HPV Vaccine
By Stacy Simon The American Cancer Society is supporting a call-to-action from dozens of National Cancer Institute-designated Cancer Centers across the US urging action to increase vaccination against human papillomavirus (HPV). HPV vaccines protect against high-risk types of the virus that cause most cervical cancers. The virus is also linked to cancers of the vulva, vagina, penis, anus, and throat. Despite this, vaccination rates across the US remain low. According to the Centers for Disease Control and Prevention (CDC), only 40% of girls and 21% of boys in the US have received all 3 doses of the vaccine. The CDC recomme...
Source: American Cancer Society :: News and Features - January 27, 2016 Category: Cancer & Oncology Tags: Cervical Cancer Oral Cavity and Oropharyngeal Cancer Anal Cancer Vulvar Cancer Vaginal Cancer Source Type: news
Medtech approvals: FDA releases November 2015 PMAs
The FDA today released its list of the pre-market approvals it granted for medical devices in November 2015:
Summary of PMA Originals & Supplements Approved
Originals: 3
Supplements: 69
Summary of PMA Originals Under Review
Total Under Review: 57
Total Active: 30
Total On Hold: 27
Summary of PMA Supplements Under Review
Total Under Review: 583
Total Active: 433
Total On Hold: 150
Summary of All PMA Submissions
Originals: 4
Supplements: 75
Summary of PMA Supplement PMA Approval/Denial Decision Times
Number of Approvals: 69
Number of Denials: 0
Average Days Fr Receipt to Decision (Total Time): 193.4
FDA Time: 1...
Source: Mass Device - January 22, 2016 Category: Medical Equipment Authors: MassDevice Tags: Food & Drug Administration (FDA) Regulatory/Compliance Source Type: news
Boston Medical Center receives $1 million grant to improve communication about HPV vaccine
(Boston University Medical Center) Researchers at Boston Medical Center were awarded a three-year, $1.04 million grant from the American Cancer Society to expand an education-based pilot program to improve communication between pediatric physicians and their patients about the Human Papillomavirus vaccine. During the pilot study, vaccination rates increased as physicians became more educated about HPV vaccination. This grant will expand this intervention to five additional community health centers in Boston to test its efficacy in a larger, diverse group of patients and families. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 22, 2015 Category: Cancer & Oncology Source Type: news
